1. High CyPA expression in non-small cell lung cancer and its relationship with clinical pathological characteristics
Academic Journal of Second Military Medical University 2010;29(2):146-149
Objective: To investigate the expression and distribution of CyPA in non-small cell lung cancer (NSCLC) and to evaluate its clinical significance in the development and progression of NSCLC. Methods: The expression of CyPA was examined in 45 NSCLC tissues, 22 paired tumor-adjacent tissues and 33 normal pulmonary tissues using tissue microarray immunohistochemistry method. The relationship between CyPA expression in NSCLC and clinic pathological characteristics of NSCLC was analyzed. Results: Expression of CyPA in NSCLC tissues and paired tumor-adjacent tissues was significantly higher than that in the normal pulmonary tissues (P<0.05). No significant correlation was found between the expression of CyPA and differentiation and histological types of NSCLC. Conclusion: CyPA is overexpressed in NSCLC tissues, suggesting that CyPA might serve as a biomarker for the development and progression of NSCLC, whose specific role remains to be further studied.
2.An epidemiologic study of diabetes mellitus in adolescents in Hanjiang district, Yangzhou
Yanling GAO ; Yan XU ; Jun ZHANG ; Feng SUN ; Ming YANG
Chinese Journal of Endocrinology and Metabolism 2008;24(6):643-644
The prevalence of diabetes mellitus and its relative risk factors in adolescents were investigated in Hanjiang district, Yangzhou. A total of 2 153 adolescents aged from 16 to 18 years old from 7 high schools were enrolled. The prevalence of diabetes mellitus and impaired fasting glucose was 6.13% and 16.12%, respectively. The independent risk factors are obesity or overweight.
3.Clinical study on parotidectomy with facial nerve dissection under microscope.
Yun-ping FAN ; Shao-yan FENG ; Ming-hui LÜ
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2010;45(8):685-686
Adolescent
;
Adult
;
Aged
;
Facial Nerve
;
anatomy & histology
;
pathology
;
Female
;
Humans
;
Male
;
Microsurgery
;
Middle Aged
;
Parotid Neoplasms
;
surgery
;
Young Adult
4.Dengzhan Xixin injection as an adjuvant treatment for angina pectoris: a systematic review and Meta-analysis of randomized controlled trials.
Feng-jiao WANG ; Yan-ming XIE ; Xing LIAO ; Min JIA
China Journal of Chinese Materia Medica 2015;40(16):3298-3307
The paper is to systematically evaluate the efficacy and safety of Deng Zhan Xi Xin injection ( DZXXI) as an adjuvant treatment for patients with angina pectoris. The Cochrane Library, Medline, EMbase, CBM, CNKI, VIP, and Wan fang Data base were searched. Randomized controlled trials (RCTs) of DZXXI combined with western medicine routine treatment versus western medicine routine treatment alone for angina pectoris patients were all included. All trials were assessed according to the Cochrane Reviewer' s Handbook 5.1 for Systematic Reviews of Intervention and Meta analyses were performed by RevMan 5. 2 Software. A total of 30RCTs (3 086 patients including 1 572 patients of treatment group and 1 514 patients of control group) were included. Meta-analysis of treatment group compared with control group showed superior effect over reducing cardiovascular events ( OR = 0.33; 95% CI: [0.16, 0.67], P = 0.002, improving effective rate of DZXXI as adjuvant treatment for angina pectoris patients (OR = 3.97; 95% CI: [3.15, 5.02]; P < 0.000 010 and electrocardiogram curative effect (OR = 2.21; 95% CI; [1.83, 2.68]; P < 0.000 010. Funnel figure seemed that there was publication bias. The current limited evidence showed that when compared with the control group, treatment group was superior in improving patients with angina pectoris. But based on the limitations of the study, rigorous design with long follow up clinical trials are necessary for further evidence.
Adjuvants, Pharmaceutic
;
Adult
;
Aged
;
Angina Pectoris
;
drug therapy
;
physiopathology
;
Drugs, Chinese Herbal
;
administration & dosage
;
Electrocardiography
;
Female
;
Heart
;
physiopathology
;
Humans
;
Injections
;
Male
;
Middle Aged
;
Randomized Controlled Trials as Topic
5.Real-world analysis of concurrent diseases and medicine use among patients with insomnia.
Jie-Feng CUI ; Wei YANG ; Yan-Ming XIE ; Yong SUN ; Yan ZHUANG ; Yong-Yan WANG
China Journal of Chinese Materia Medica 2014;39(18):3519-3526
This study aims to explore and analyze the condition of concurrent diseases and medicine use of traditional Chinese medicine (TCM) and western medicine among the patients with insomnia. One thousand and sxity seven cases of data from 20 national hospitals' hospital information system (HIS) databases were collected. The frequent concurrent diseases included hypertension (26.9%), brain blood supply insufficiency (24.93%), cerebral infarction (19.49%), blood lipoprotein disturbance (15.28%), coronary heart disease (14.15%), headache (10.68%), chronic gastritis (8.81%), type 2 diabetes mellitus (7.87%), depressive disorder (7.4%) and anxiety disorder (6.65%). The 10 most frequently-used western drugs included alprazolam (35.99%), aspirin (25.4%), olanzapine (24.18%), cinepazide (23.06%), flupentixol & melitracen (18.74%), zolpidem (18.37%), oxiracetam (15.65%), estazolam (15%), aniracetam (13.4%) and piracetam (13.31%). The 10 most frequently-used TCM included Shuxuening injection (16.4%), Shuxuetong injection (15.18%), extract of ginkgo biloba leaf (14.71%), gastrodin (12.46%), Dengzanxixin injection (11.34%), Xueshuantong (8.53%), Danhong injection (6.37%), compound liquorice tablet (5.81%), Sanqi Tongshu capsule (5.72%) and sowthistle-leaf ixeridium injection (5.34%). Among all combined uses, the most frequent western drug use was alprazolam and olanzapine, while combined use of hypnotic drug and Huoxuehuayu formula is the most frequent. This study concludes that the concurrent diseases mainly include cardio-cerebrovascular diseases, metabolic disorders and anxiety-depression disorders, with increasing tendency of diseases types by ages, especially for cardio-cerebrovascular diseases. The most frequently-used hypnotic is alprazolam in the insomnia patients, and it is worth being concerned about the off-label use of olanzapine as an antipsychotic for the treatment of insomnia However, due to the fact that all cases data are from the inpatients, these findings have some limitations.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Alprazolam
;
therapeutic use
;
Anti-Anxiety Agents
;
therapeutic use
;
Antipsychotic Agents
;
therapeutic use
;
Benzodiazepines
;
therapeutic use
;
Cerebral Infarction
;
drug therapy
;
epidemiology
;
etiology
;
Coronary Disease
;
drug therapy
;
epidemiology
;
etiology
;
Diabetes Mellitus, Type 2
;
drug therapy
;
epidemiology
;
etiology
;
Drugs, Chinese Herbal
;
therapeutic use
;
Female
;
Headache
;
drug therapy
;
epidemiology
;
etiology
;
Humans
;
Hypertension
;
drug therapy
;
epidemiology
;
etiology
;
Male
;
Medicine, Chinese Traditional
;
Middle Aged
;
Sleep Initiation and Maintenance Disorders
;
complications
;
drug therapy
;
epidemiology
;
Young Adult
6.Establishment and identification of stable cell line secreting humen IgE Cε-4 protein
Chunxia QIAO ; Leiming GUO ; Ming Lü ; Ming YU ; Yan LI ; Jiannan FENG ; Beifen SHEN
Chinese Journal of Microbiology and Immunology 2008;28(7):661-665
Objective To establish a stable cell line secreting human IgE Cε2-4 protein, and in-vestigate the binding capacity of receptor FcεR Ⅰ Methods The E24 gene was derived from SKO-O07 cell line, and was then cloned into pcDNA3.1 (+) (signal peptides were synthesized and fused at the 5'-end of E24 gene) or pCMV-L vector. After transient transfection into 293T cell, the secreted F24 protein was ana-lyzed by sandwich ELISA. The best vector was chosen to be transfected into CHO cells with LipofectAMI-NETM 2000 reagent. After being selected by G418 and subcloned three times by limited-dilution method, two stable cell lines were established. E24 gene was amplified by RT-PCR, and the E24 protein in the superna-tant was identified by ELISA. Besides, the binding capacity of FceR ⅠⅡ was analyzed by flow cytometry method. Results Three mammalian expression vector SP-E24-F3. 1, SP lI-E24-P3.1 and E24-PL were constructed and transient transfected to 293T cells. The output of E24 protein in the supernatant were 19.1, 19.4 and 8.7 μg/ml, respectively. Then the vector SP IX-E24-P3.1 was transfected into CHO cells. Final-ly, two single clones secreting E24 protein were stably obtained. The output of E24 were all at least 25 μg/ml. RT-PCR could detect the E24 gene from one of the two clones. Furthermore, flow cytometry results showed that E24 could bind the receptor in a dose-dependent manner. Conclusion Two stable cell line se- creting E24 protein were obtained, while E24 could specifically bind FcεR Ⅰ.
7.Relationship between Cough Variant Asthma and Mycoplasma Pneumoniae Infections
dong-ming, HUANG ; xiao-xiong, XIAO ; xiao-ling, HE ; yan-hui, FENG ; yu-ming, CHEN
Journal of Applied Clinical Pediatrics 1994;0(04):-
Objective To explore the relationship between cough variant asthma (CVA) and mycoplasma pneumoniae (MP) infection.Methods Fifty children with CVA were chosen as the experimental group at random,and 50 children with acute upper respiratory infection,who went to the hospital in the same time and with similar age,were chosen as control group.The MP-IgM of children in both groups were tested by the granule agglutinating method.Results Significant difference (? 2=9.013 P
9.Serum Myeloperoxidase Level in Systemic Lupus Erythematosus.
Ming-jian BAI ; Jing FENG ; Feng YU ; Cun-ling YAN ; Chan-juan CUI ; Lei HUANG ; Zhen-ru FENG
Chinese Medical Sciences Journal 2015;30(3):199-202
Adult
;
Female
;
Humans
;
Lupus Erythematosus, Systemic
;
enzymology
;
Male
;
Middle Aged
;
Peroxidase
;
blood
10.Expression of ITF Gene in Lacococcus lactis
Cai-Ming BAI ; Yan-Wei BI ; Xu YANG ; Zhi-Hua LI ; Jian-Feng LI ; Wei-Ming XU ;
China Biotechnology 2006;0(10):-
To develop an oral drug,ITF gene encoding ITF proein,was expressed in a live delivery vehicle lactococcus lactis.First,the ITF gene was cloned into the prokaryotic expressive vector pNICE:sec.Second,the recombinant vector pNICE:sec-ITF was transformated into Lactococcus lactis strain NZ9000 to express ITF protein.Then the recombinant ITF was induced to express and was identified by SDS-PAGE and Western blot.Rabbits are divided into blank control group,preparation group and therapeutic group which are respectively administrated wih PBS and pNICE:sec-ITF Lactococcus lactis.By grades of ulcer test whether administrated pNICE:sec-ITF Lactococcus lactis protects against HCl-induced gastric injury in rabbits.The results were described as follows.The ITF was amplified and cloned in the vector pNICE:sec successfully.The fusion protein(5.9kDa) was expressed in L.lactis by the induction of the nisin.The quantity of expression accounted for 5% of the total bacterial protein.Western bolt analysis confirmed that fusion protein could be recognized specially by Monoclonal Anti-human TFF3 Antibody.Preparation groups and therapeutic groups do good than control group.Prove that administrated pNICE:sec-ITF Lactococcus lactis is biologically active in an HCl-induced rabbit gastric mucosal injury model.